Back
Alnylam Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$308.42
Seasonality Move:
-5.16%
7 Day Trial
ALL ACCESS PASS
$
7
Alnylam Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 33.7% based on the past 21 years of stock performance.
-
Alnylam Pharmaceuticals, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
-
Is Alnylam Pharmaceuticals, Inc. Stock Undervalued?The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $322.28. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 33.7% based on the past 21 years of stock performance.
Alnylam Pharmaceuticals, Inc. Stock Rating
Sell
23
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. overpriced?
-
Alnylam Pharmaceuticals, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
Alnylam Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
495.55
52-Week Low:
205.87
Prediction Charts
Market Cap:
42.6B
Price in USD:
322.28
Volume:
1.6M
Beta:
1.19
Technical Analysis
SMA50:
386.35
SMA100:
421.18
SMA200:
385.92
52-Wk Change:
19.81%
Stock Predictions
-
Is Alnylam Pharmaceuticals, Inc. stock public?Yes, Alnylam Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Alnylam Pharmaceuticals, Inc. stock quote today?The Alnylam Pharmaceuticals, Inc. stock price is 322.28 USD today.
-
How to buy Alnylam Pharmaceuticals, Inc. stock online?You can buy Alnylam Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-23 | 368.20 | 357.98 | 371.33 | 356.72 |
| Jan-26 | 357.98 | 361.35 | 364.07 | 352.50 |
| Jan-27 | 361.55 | 354.75 | 368.07 | 354.69 |
| Jan-28 | 353.66 | 349.58 | 356.84 | 348.00 |
| Jan-29 | 349.37 | 346.79 | 350.34 | 345.01 |
| Jan-30 | 343.10 | 338.06 | 346.50 | 336.39 |
| Feb-2 | 337.42 | 339.11 | 342.33 | 333.00 |
| Feb-3 | 338.49 | 351.80 | 352.82 | 337.59 |
| Feb-4 | 354.00 | 351.96 | 355.49 | 347.08 |
| Feb-5 | 350.50 | 331.24 | 350.50 | 327.27 |
| Feb-6 | 331.61 | 328.16 | 340.07 | 326.51 |
| Feb-9 | 325.49 | 320.00 | 329.92 | 319.26 |
| Feb-10 | 322.68 | 322.98 | 325.98 | 317.89 |
| Feb-11 | 322.14 | 322.28 | 325.04 | 317.80 |
Alnylam Pharmaceuticals, Inc. Earnings
Alnylam Pharmaceuticals, Inc. Earnings Report: Per Share Alnylam Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals, Inc. Forecast Revenue Growth
Alnylam Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.80 per share, and an increase next year of $5.33 per share.
* Alnylam Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.